-
Project Manager – Quality Management (AI-based Medical Device)
Are you passionate about advancing molecular precision diagnostics for cancer patients? Do you thrive in a dynamic, fast-paced environment, and have first experience in quality management for medical devices? We are looking for a Project Manager to help maintain and further develop our quality management system as we move towards […]
-
Heidelberg Epignostix appoints Helge Lubenow as CEO
Heidelberg, Germany, July 16, 2024 – Heidelberg Epignostix, a deeptech start-up committed to precision cancer diagnostics today announces the appointment of Helge Lubenow as CEO. She will be succeeding founder David Jones in the role who will continue to support Heidelberg Epignostix as Chief Scientific Officer. Helge Lubenow has almost 25 […]
-
DKFZ spin-off Epignostix raises €4.3m seed round to commercialize diagnostic tumor classifier
Heidelberg, Germany, July 2, 2024 – Heidelberg Epignostix GmbH, a deeptech start-up committed to precision cancer diagnostics today announces €4.3M in seed funding. This investment will enable Heidelberg Epignostix to make a substantial leap forward in driving market development for its flagship indication for brain tumor classification. CARMA FUND I Capital GmbH […]
